Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 32.86 USD -0.42% Market Closed
Market Cap: 201.1m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of MNPR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MNPR Intrinsic Value
Not Available
Base Case Scenario
Compare MNPR to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MNPR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Monopar Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Monopar Therapeutics Inc

Current Assets 55.1m
Cash & Short-Term Investments 54.6m
Other Current Assets 523.5k
Non-Current Assets 9.1k
PP&E 9.1k
Efficiency

Free Cash Flow Analysis
Monopar Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Monopar Therapeutics Inc

Revenue
0 USD
Operating Expenses
-17.7m USD
Operating Income
-17.7m USD
Other Expenses
1.1m USD
Net Income
-16.6m USD
Fundamental Scores

MNPR Profitability Score
Profitability Due Diligence

Monopar Therapeutics Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

Monopar Therapeutics Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

MNPR Solvency Score
Solvency Due Diligence

Monopar Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Monopar Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MNPR Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast MNPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNPR is 59.16 USD with a low forecast of 40.4 USD and a high forecast of 79.8 USD.

Lowest
Price Target
40.4 USD
23% Upside
Average
Price Target
59.16 USD
80% Upside
Highest
Price Target
79.8 USD
143% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Monopar Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MNPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MNPR Insider Trading
Buy and sell transactions by insiders